Clinical Trials · NCT03996837

Platelet Rich Plasma and Recurrent Implantation Failure

CompletedN/AGonadorelin (Approved)
Phase
N/A
Recruitment status
Completed
Sponsor
Royan Institute
Enrollment
80
Start date
Aug 2017
Locations
1 site, Iran
Primary endpoint
Implantation rate
View Gonadorelin compound reference